Leerink Swann Upgrades Medicines Company To Outperform

By: via Benzinga
Analysts at Leerink Swann upgraded The Medicines Company (NASDAQ: MDCO) from Market Perform to Outperform. The price target for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.